ArticleCell host & microbe2023
Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox.
Abstract read
In one paragraph
Article in Cell host & microbe, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed.
- The challenge and promise of studying human antigen-specific T cells.Nature reviews. Immunology · 2026Review
- MPXV H3L elicits broadly directed CD4 T cell responses in mpox patients and MVA vaccinees.Npj viruses · 2026Article
- A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinations.Molecular therapy. Advances · 2026Article
- Durable but impaired humoral and cellular immune responses against monkeypox virus in people with HIV over 18 months.Journal of translational medicine · 2026Article
- A comparison of two- and three-dose MVA-BN mpox vaccination series on anti-monkeypox virus immunity.NPJ vaccines · 2026Article
- Waning humoral immunity following monkeypox virus infection and vaccination, Canada, 2020 to 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026Observational
- Metabolic quiescence of naive-like memory T cells precedes and maintains antigen-specific T cell memory.Nature immunology · 2026Article
- Protective efficacy of a genetically modified attenuated vaccinia virus Tiantan strain against monkeypox virus challenge in a small animal model.Journal of virology · 2026Article
- Insights into Monkeypox Virus: Host Immunity, Viral Immune Evasion, Recent Advances in Vaccines, Therapeutic Development, and Future Perspectives.Microorganisms · 2026Review
- Robust Adaptive Immunity to MPXV in Older People Who Received Childhood Vaccinia Vaccination.Biology · 2026Article
- Vaccinia virus for lung cancer therapy: preclinical progress and prospects as a systemic immunotherapy platform.Frontiers in immunology · 2026Review
- Immune profiling of mpox survivors reveals divergent durability of antibody and T cell responses.Nature communications · 2025Article
- An mpox quadrivalent mRNA vaccine elicits sustained and protective immunity in mice against lethal vaccinia virus challenge.Emerging microbes & infections · 2025Article
- Vδ2 T-cells response in people with Mpox infection: a three-month longitudinal assessment.Emerging microbes & infections · 2025Article
- Article
- Tiantan vaccinia virus-based vaccine with promising safety provides sustained protection against mpox in non-human primates.Nature communications · 2025Article
- T cell memory response to MPXV infection exhibits greater effector function and migratory potential compared to MVA-BN vaccination.Nature communications · 2025Article
- Identification of soluble biomarkers that associate with distinct manifestations of long COVID.Nature immunology · 2025Article
- An mRNA vaccine against monkeypox virus inhibits infection by co-activation of humoral and cellular immune responses.Nature communications · 2025Article
- Antigen recognition and immune response to monkeypox virus infection: implications for Mpox vaccine design - a narrative review.Le infezioni in medicina · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Sarah AdamoDepartment of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm 14152, Sweden.
Yu GaoDepartment of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm 14152, Sweden.
Takuya SekineDepartment of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm 14152, Sweden.
Akhirunnesa MilyDepartment of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm 14152, Sweden.
Jinghua WuDepartment of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm 14152, Sweden.
Elisabet StorgärdDepartment of Infectious Diseases/Venhälsan, Södersjukhuset, Stockholm 11861, Sweden.
Victor WestergrenDepartment of Infectious Diseases/Venhälsan, Södersjukhuset, Stockholm 11861, Sweden.
Finn FilénDepartment of Infectious Diseases/Venhälsan, Södersjukhuset, Stockholm 11861, Sweden.
Carl-Johan TreutigerDepartment of Infectious Diseases/Venhälsan, Södersjukhuset, Stockholm 11861, Sweden.
Johan K SandbergDepartment of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm 14152, Sweden.
Matti SällbergDepartment of Laboratory Medicine, Division of Clinical Immunology, Karolinska Institutet, Stockholm 14152, Sweden.
Peter BergmanDepartment of Laboratory Medicine, Division of Clinical Immunology, Karolinska Institutet, Stockholm 14152, Sweden; Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm 14152, Sweden.
Sian Llewellyn-LaceyDivision of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff CF14 4ER, UK.
Hans-Gustaf LjunggrenDepartment of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm 14152, Sweden.
David A PriceDivision of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff CF14 4ER, UK; Systems Immunity Research Institute, Cardiff University School of Medicine, University Hospital of Wales, Cardiff CF14 4ER, UK.
Anna-Mia EkströmDepartment of Infectious Diseases/Venhälsan, Södersjukhuset, Stockholm 11861, Sweden; Department of Global Public Health, Karolinska Institutet, Stockholm 17176, Sweden.
Alessandro SetteCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA; Department of Pathology, University of California, San Diego, La Jolla, CA 92093, USA.
Alba GrifoniCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA.
Marcus BuggertDepartment of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm 14152, Sweden. Electronic address: marcus.buggert@ki.se.
Funding
Large Scale T Cell Epitope Discovery:Global identification of epitopes derived from Zika (ZIKV), Chikungunya (CHIKV) viruses following natural infection and vaccination75N93019C00065 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI MITCHELL, MAYA · 2019 to 2023
$7.3MNIAID NIH HHS 75N93019C00065
Abstract
Mpox represents a persistent health concern with varying disease severity. Reinfections with mpox virus (MPXV) are rare, possibly indicating effective memory responses to MPXV or related poxviruses, notably vaccinia virus (VACV) from smallpox vaccination. We assessed cross-reactive and virus-specific CD4
Indexed as
Mpox, MonkeypoxPoxviridaeSmallpoxCD8-Positive T-LymphocytesHumansVaccinia virusinfectious diseaseslong-lived memory T cellsmonkeypoxmpoxMPXVT cellsvaccinia virusVACVviral immunity
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.